Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...
TikTok Has A Simple Exit From U.S. Ban Maze
With Trump back in charge, a long list of mooted, familiar buyers is re-emerging. The simplest way to scroll past this glitch ...
FierceBiotech11d
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
Maze Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Maze Therapeutics, Inc MAZE IPO will take place January, 31 on the NASDAQ exchange under the ticker MAZE. The company is offering shares at an expected price between $15.00 and $17.00 per share with ...
MinnPost9d
Is Minnesota home to the largest ice maze in the world?
Until this year, the Guinness World Record was held by a nearly 13,000-square-foot ice labyrinth in New York that took the ...
Wes Ball, Joe Hartwick And Their OddBall Entertainment Ink With CAA
EXCLUSIVE: The Maze Runner filmmakers and their OddBall Entertainment studio have signed with CAA, we can tell you. Wes Ball ...